| Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials Q Shi, Y Wang, Q Hao, PO Vandvik, G Guyatt, J Li, Z Chen, S Xu, Y Shen, ... The Lancet 399 (10321), 259-269, 2022 | 270 | 2022 |
| Cardiovascular effects of dipeptidyl peptidase-4 inhibitor in diabetic patients with and without established cardiovascular disease: a meta-analysis and systematic review S Xu, X Zhang, L Tang, F Zhang, N Tong Postgraduate medicine 129 (2), 205-215, 2017 | 32 | 2017 |
| Impact of acarbose on incident diabetes and regression to normoglycemia in people with coronary heart disease and impaired glucose tolerance: insights from the ACE trial HC Gerstein, RL Coleman, CAB Scott, S Xu, J Tuomilehto, L Ryden, ... Diabetes Care 43 (9), 2242-2247, 2020 | 25 | 2020 |
| Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials Q Shi, Y Wang, Q Hao, PO Vandvik, G Guyatt, J Li, Z Chen, S Xu, Y Shen, ... The Lancet 403 (10434), e21-e31, 2024 | 21 | 2024 |
| Acarbose with comparable glucose-lowering but superior weight-loss efficacy to dipeptidyl peptidase-4 inhibitors: a systematic review and network meta-analysis of randomized … F Zhang, S Xu, L Tang, X Pan, N Tong Frontiers in endocrinology 11, 288, 2020 | 21 | 2020 |
| Systemic delivery of siRNA specific for silencing TLR4 gene expression reduces diabetic cardiomyopathy in a mouse model of streptozotocin-induced type 1 diabetes Y Zhang, Y Li, X Huang, F Zhang, L Tang, S Xu, Y Liu, N Tong, W Min Diabetes Therapy 11, 1161-1173, 2020 | 19 | 2020 |
| The effects of DPP-4 inhibitors, GLP-1RAs, and SGLT-2/1 inhibitors on heart failure outcomes in diabetic patients with and without heart failure history: Insights from CVOTs … X Pan, S Xu, J Li, N Tong Frontiers in Endocrinology 11, 599355, 2020 | 15 | 2020 |
| The association between sex hormones and periodontitis among American adults: A cross-sectional study X Su, K Jin, X Zhou, Z Zhang, C Zhang, Y Li, M Yang, X Huang, S Xu, ... Frontiers in Endocrinology 14, 1125819, 2023 | 13 | 2023 |
| Activated PPARβ/δ Protects Pancreatic β Cells in Type 2 Diabetic Goto–Kakizaki Rats from Lipoapoptosis via GPR40 J Li, S Xu, Y Liu, Z Yan, F Zhang, Q Lv, N Tong Lipids 54 (10), 603-616, 2019 | 10 | 2019 |
| Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance S Xu, CAB Scott, RL Coleman, J Tuomilehto, RR Holman Journal of Diabetes 13 (10), 817-826, 2021 | 8 | 2021 |
| Pheochromocytoma crisis presenting with hypotension, hemoptysis, and abnormal liver function: a case report R Wu, N Tong, X Chen, S Xu, F Zhang, L Tang, Y Zhang Medicine 97 (25), e11054, 2018 | 7 | 2018 |
| Evaluation of the value of diabetes risk scores in screening for undiagnosed diabetes and prediabetes: a community-based study in southwestern China S Xu, Y Wu, J Li, X Pan, X Zhang, Y Liu, F Zhang, N Tong Postgraduate Medicine 132 (8), 737-745, 2020 | 5 | 2020 |
| Childhood maltreatment and risk of endocrine diseases: an exploration of mediating pathways using sequential mediation analysis S Wen, J Zhu, X Han, Y Li, H Liu, H Yang, C Hou, S Xu, J Wang, Y Hu, ... BMC medicine 22 (1), 59, 2024 | 4 | 2024 |
| Risk prediction models for incident type 2 diabetes in Chinese people with intermediate hyperglycemia: a systematic literature review and external validation study S Xu, RL Coleman, Q Wan, Y Gu, G Meng, K Song, Z Shi, Q Xie, ... Cardiovascular Diabetology 21 (1), 182, 2022 | 3 | 2022 |
| Association between body composition patterns, cardiovascular disease, and risk of neurodegenerative disease in the UK biobank S Xu, S Wen, Y Yang, J He, H Yang, Y Qu, Y Zeng, J Zhu, F Fang, H Song Neurology 103 (4), e209659, 2024 | 2 | 2024 |
| Adverse health consequences of undiagnosed hearing loss at middle age: A prospective cohort study with the UK Biobank S Xu, C Hou, X Han, Y Hu, H Yang, Y Shang, W Chen, Y Zeng, Z Ying, ... Maturitas 174, 30-38, 2023 | 1 | 2023 |
| Association Between Early‐Life and Premorbid Measurements of Body Composition and Risk of Motor Neuron Disease: A Prospective Cohort Study in the UK Biobank EE Joyce, S Xu, C Ingre, RL Potenza, C Seitz, H Yang, Y Zeng, H Song, ... Annals of Neurology, 2024 | | 2024 |
| Risk-prediction models for incident type 2 diabetes in Chinese people with impaired glucose tolerance: a systematic literature review and external validation study S Xu, Q Wan, R Coleman, J Tuomilehto, N Tong, RR Holman The Lancet 396, S7, 2020 | | 2020 |
| Diabetes Care Publish Ahead of Print, published online July 8, 2020 HC Gerstein, RL Coleman, CAB Scott, S Xu, J Tuomilehto, L Rydén | | 2020 |
| 2436-PUB: Predicting Risk for New-Onset Type 2 Diabetes in Chinese People with Coronary Heart Disease and Impaired Glucose Tolerance S Xu, CA Scott, RL Coleman, J Tuomilehto, RR Holman Diabetes 68 (Supplement_1), 2019 | | 2019 |
Huan SongWest China Biomedical Big Data Center, West China Hospital, Sichuan University在 wchscu.cn 的电子邮件经过验证
